SightSciences_Logo_2C_RGB.png
Sight Sciences Reports First Quarter 2022 Financial Results
May 10, 2022 16:05 ET | Sight Sciences, Inc.
MENLO PARK, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
SightSciences_Logo_2C_RGB.png
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
April 29, 2022 08:00 ET | Sight Sciences, Inc.
MENLO PARK, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) an eyecare technology company focused on creating innovative solutions intended to transform care and...
SightSciences_Logo_2C_RGB.png
Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting
April 20, 2022 16:05 ET | Sight Sciences, Inc.
MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
SightSciences_Logo_2C_RGB.png
Sight Sciences to Report First Quarter 2022 Financial Results on May 10, 2022
April 14, 2022 16:05 ET | Sight Sciences, Inc.
MENLO PARK, Calif., April 14, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
SightSciences_Logo_2C_RGB.png
Sight Sciences Reports Fourth Quarter and Full Year 2021 Financial Results
March 24, 2022 16:05 ET | Sight Sciences, Inc.
MENLO PARK, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of...
SightSciences_Logo_2C_RGB.png
Sight Sciences Announces First Patient Treated in TRIDENT European Trial to Evaluate the OMNI® Surgical System in Pseudophakic Eyes with Open-Angle Glaucoma
March 24, 2022 16:04 ET | Sight Sciences, Inc.
MENLO PARK, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
SightSciences_Logo_2C_RGB.png
Sight Sciences Announces Appointment of Brenda Becker to Board of Directors
March 16, 2022 08:00 ET | Sight Sciences, Inc.
MENLO PARK, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
SightSciences_Logo_2C_RGB.png
Sight Sciences to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022
March 03, 2022 16:05 ET | Sight Sciences, Inc.
MENLO PARK, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
SightSciences_Logo_2C_RGB.png
Sight Sciences Announces Multiple Presentations at the 2022 American Glaucoma Society Annual Meeting
March 02, 2022 08:00 ET | Sight Sciences, Inc.
MENLO PARK, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
SightSciences_Logo_2C_RGB.png
Sight Sciences to Participate in the Upcoming Citi Virtual Healthcare Conference
February 21, 2022 16:05 ET | Sight Sciences, Inc.
MENLO PARK, Calif., Feb. 21, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of...